Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
About this episode
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.
CME information and select publications here.
Get every episode summarized
Each time Hematologic Oncology Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Hematologic Oncology Update
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal S...
Hematologic Oncology Update
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Pre...
Hematologic Oncology Update
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH...
Hematologic Oncology Update
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH...
Hematologic Oncology Update